and whole gut transit (p<O0O5) when compared with the normal subjects. There was no significant difference in gastric emptying between the two groups. Treatment with loperamide-N-oxide was associated with a reduced frequency of* bowel actions (p<0001), slower small intestinal (p<0001), and total gut transit (p<001), more rapid gastric emptying (p<001), improved absorption of bile acid (p<001), and increased permeability to 51Cr EDTA (p<0.01). These observations indicate
that: (1) diarrhoea caused by chronic radiation enteritis is associated with more rapid intestinal transit and a high prevalence of bile acid and lactose malabsorption, and (2) loperamide-N-oxide slows small intestinal transit, increases bile acid absorption, and is effective in the treatment of diarrhoea associated with chronic radiation enteritis. (Gut 1993; 34: 476-482) Chronic radiation enteritis is now (18-8-31-4) ) with persistent diarrhoea 3-22 years after therapeutic pelvic irradiation for carcinoma of the genitourinary tract (see Table I for individual patient characteristics) were studied. The study protocol was approved by the Ethics Committee of the Royal Adelaide Hospital on March 30, 1989 and each subject gave written informed consent.
MEASUREMENTS

Gastrointestinal symptoms
The following symptoms were assessed by questionnaire on entry into the study and at the end of each phase of the study8: (i) nausea, (ii) vomiting, (iii) abdominal pain, (iv) frequency of bowel actions (number of bowel actions per week) and stool consistency (hard formed, soft formed, loose or watery). Except for (iv), each symptom was scored according to the following classification: 0 -symptom absent; 1 -mild, symptom could be ignored if the subject did not think about it; 2 -moderate, symptom could not be ignored but did not influence daily activities; 3 -severe, symptom influenced daily activities.8
The total score (maximum 9) was then calculated for each phase of the study. The frequency and consistency of bowel actions for the 2 week periods on loperamide oxide and placebo and during the wash-out period were recorded in a diary. The number of bowel actions each week was calculated. The number of bowel actions in each three day faecal collection was also recorded.
A questionnaire was also used to record dietary intake of milk products and fat and the presence or absence of intolerance to milk or milk products (symptoms of nausea, abdominal bloating, abdominal cramps, or diarrhoea) after each subject had been enrolled into the study. Intake 75Se was then swallowed with 30 ml water. Four hours later the number of counts in both the 58Co and 75Se photo peak windows were determined.67 This figure, after correction for room background counts (and down-scatter counts from the 58Co into the 75Se photo peak windows) was considered to represent 100% whole body retention. There was no significant difference between the 58Co counts at baseline and at 4 hours. Seven days later at 0900 h the counts in both 58Co and 75Se photo peak windows were again measured. This number, after correction for room background counts, radionuclide decay, and Compton scatter was used to derive the percentage whole body retention of bile acid and vitamin B 12.67 Although the second measurement of vitamin B12 and bile acid absorption was made at least 4 weeks later, a correction for patient background counts was made by first counting the residual counts in both the 58Co and 75Se photo peak windows before the administration of the second doses of 58Co vitamin B12 and SeHCAT. Otherwise an identical protocol was observed.
Dietary fat absorption was assessed by measuring the fat content in a 3 day collection of faeces, using a standard method modified for extraction of fatty acids into chloroform.'0 Lactose absorption was assessed by measurement of breath hydrogen concentrations after an oral lactose load. Each subject fasted overnight and at 0900 h was given 50 g lactose dissolved in 200 ml water, after an antiseptic mouth wash and a baseline end expiratory breath sample had been taken. Subsequent end expiratory breath samples were obtained at least every 30 minutes for up to 4 hours. All breath samples were analysed for hydrogen concentration using a sensitive chromatographic method, capable of detecting concentrations as low as 1 ppm. A sustained peak in breath hydrogen greater than 10 ppm was taken to indicate malabsorption of lactose." The day after the performance of this test, patients were asked (by one of the investigators who was unaware of the hydrogen analysis) whether symptoms of nausea, abdominal bloating, cramps, or diarrhoea occurred within 8 hours of the lactose load."
Gastrointestinal transit At 0830 h, after an overnight fast (from 2200 h on the evening before the test) each subject ingested 200 ml water containing 10g lactulose (DuphalacDuphar, Holland), 20 g dextrose, 40 mBQ 99mTc-sulphur colloid and 50 radio-opaque plastic markers over a period of 2 minutes."24 The subject then laid supine under a wide field view gamma camera. A cobalt marker was placed at the right anterior superior iliac crest to aid alignment of images. Data were acquired for a minimum of 5 hours. For the first 30 minutes after meal completion data were sampled every minute, followed by 3 minute frames for the remainder of the study. End expiratory breath samples were taken at 10-15 minute intervals after ingestion of the meal for breath hydrogen analysis. During the study the subject was allowed to sit up, or walk around briefly if they wished every 60 minutes.
Regions of interest were drawn around the stomach and colon. 12 4 After data were corrected for radionuclide decay, scatter, and gamma ray attenuation, using previously described methods," time-activity curves characterising gastric emptying and colonic filling were derived. By a process of computer subtraction a time activity curve representing small intestinal transit was also obtained. 'I Time zero was considered the time of completion of the test meal. A sustained rise in the breath hydrogen concentration >5 ppm was considered to represent the arrival of the meal at the caecum. 16 For gastric emptying, the lag phase before any of the meal emptied from the stomach and the 50% emptying time were determined. For small intestinal transit the following parameters were determined: (i) start of colonic filling (arrival of head of meal assessed scintigraphically and by breath hydrogen measurements)'6; (ii) small intestinal transit (start of colonic filling minus the lag phase for gastric emptying); (iii) small intestinal residence (area under derived small intestinal transit time activity curve); (iv) time for 50% colonic filling. 14 Whole gut transit was determined radiographically by the first arrival of the radio-opaque marker(s) and the time when 50% or more of the radio-opaque markers were in the stool. 2 Intestinal permeability This was assessed by two tests.
(1) Urinary excretion of51CrEDTA. Each subject was initially asked to collect their urine for 24 hours. At 0930 h after an overnight fast (from 2400 h the subject ingested 2-10 ml of 51Cr EDTA (Australian Atomic Energy Commission, code no CRIMI) containing 750 kBQ of 5'Cr, followed by 300 ml water. Fasting was maintained for a further 2 hours, after which a normal diet was permitted. Patients were instructed to take no alcohol and to collect all urine for the next 24 hours. The entire 24 hour collection was counted in a large volume counter. The 24 hour urine collection before 51Cr EDTA was also counted, to correct for any background radioactivity derived from 75Se from the bile acid absorption test. The. result was expressed as a percentage of administered dose.
" l (2) Urinary excretion ofa double sugar-lactulosel rhamnose. After an overnight fast (from 2400 h, each subject-was instructed to urinate at 0900 h and was then given 22-6 g glucose, 5 g lactulose, and 1 g L-rhamnose in 100 ml of distilled water. Thirty minutes after ingestion of the test solution the patient was encouraged to drink and was instructed to collect urine over the next 5 hours. The concentration of sugars in urine was measured by high performance thin layer chromotography. After correction of the rhamnose values for urea concentration (the latter was determined in a 1 ml aliquot of urine), the results were expressed as a ratio of the 5 hour urinary excretions of lactulose and rhamnose. ' (Figure) and, after treatment, was not significantly different from values in the control group (Table IV) two groups in the lag phase, but the time for 50% gastric emptying was less during treatment with loperamide oxide (p<0 01) and gastric emptying was faster in patients after treatment with loperamide oxide (p<0 05) than in control subjects (Table IV) . In contrast, loperamide oxide delayed both small intestinal (p<0 01) and whole gut (p<001 first marker, p<0 05 50% markers) transit. During treatment with loperamide oxide, small intestinal transit and whole gut transit were not significantly different from the control group (Table IV) . There were significant relationships between stool weight and both whole gut transit (r=-0-58, p<0 01) and stool frequency (r=0-45, p<005) during treatment with loperamide oxide. Intestinal permeability, as assessed by the 5'Cr EDTA test, was greater (p<O-Ol) after treatment loperamide oxide but there was no difference in the absorption of lactulose/rhamnose (Table III) . 51Cr EDTA absorption was related to small bowel residence during both the placebo and loperamide oxide phases (r>0-45, p<0 05). changes, which inevitably occur in patients with a long history of diarrhoea. Intake of dairy products was less in the patients and probably contributed to the normal faecal fat excretion. It is also possible that in some patients concurrent radiation proctitis caused rectal irritability and contributed to a stool weight that was lower than would be predicted from stool frequency.
The SeHCAT test has made intestinal bile acid malabsorption much more easy to detect.2526 A high prevalence of bile acid malabsorption has been reported in patients with otherwise unexplained diarrhoea2627 and it has been suggested that this is of pathogenetic importance and predictive of improvement with cholestyramine. Our observation of a high prevalence of bile acid malabsorption in patients with chronic radiation enteritis is consistent with the results of a previous study.4 While vitamin B12 malabsorption has been shown in some patients,4 it is recognised that bile acid absorption is a more sensitive test of terminal ileal function than vitamin B12 absorption. 28 The reduced bile acid absorption is likely to reflect damage to the terminal ileal mucosa. It should, however, be recognised that more rapid intestinal transit, by reducing the time available for absorption, could contribute to decreased bile acid absorption and diarrhoea.62729 In particular, the terminal ileum seems to have an important role in the regulation of small intestinal transit. 30 The lactose malabsorption shown in 10 patients probably reflects mucosal damage, as small intestinal bacterial overgrowth was essentially excluded and all of the patients were white. A high prevalence of lactose malabsorption has been reported previously in patients with chronic radiation enteritis who required parenateral nutrition.3' The observation that lactose malabsorption is a common long term effect of abdominal or pelvic irradiation, or both, is important and consistent with the findings of a prospective study conducted by our group which suggests that mucosal damage in acute radiation enteritis does not resolve in many patients. Loperamide-N-oxide is a peripheral opiate agonist precursor which is converted to loperamide in the intestinal lumen37 and liver.38 Loperamide-N-oxide is itself inactive and has negligible affinity for opiate receptors.39 Plasma concentrations of loperamide after oral administration of loperamide-oxide are twofold lower than the equivalent oral doses of loperamide," resulting in a twofold increase in the already high safety margin ofloperamide.40 41 At the same time anti-diarrhoeal efficacy is maintained, since a dose of even 1 mg has been shown to be effective in a randomised double blind study of acute diarrhoea in adults. 42 As a result of the gradual activation of loperamide oxide, associated with lessened absorption of loperamide into the systemic circulation, it has been suggested that the incidence of adverse effects such as constipation may be less.4 ' Previous studies43 I which suggest that loperamide may be effective in the treatment of diarrhoea associated with acute radiation enteritis provide no insights into the mechanisms of action, as only symptoms were evaluated. Other studies indicate that loperamide may prolong intestinal transit, normalise intestinal fluid and electrolyte movement, and increase anal sphincter tone. 45 
